Parallel Advisors’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Parallel Advisors’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-6	Closed	–	–	3617
2022 Q3	$0	Buy	+6	New	+$79	﹤0.01%	3632
2022 Q1	–	Sell	-18	Closed	–	–	3408
2021 Q4	$0	Buy	+18	New	+$311	﹤0.01%	3409

Parallel Advisors's FMTX Position: Q4 2022 in Review

Parallel Advisors sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 6 shares.

Parallel Advisors first reported a position in FMTX in Q4 2021 and held it in 2 quarters. The position peaked at $0 in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Parallel Advisors reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Parallel Advisors sold 6 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022.
Parallel Advisors first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
Parallel Advisors's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $0 in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Parallel Advisors's 13F filing for Q4 2022, filed 6 Feb 2023.